Kauvery Hospital Q4 FY26: Higher occupancy and better pricing lift margins

KMC Speciality Hospitals (India) Limited, which operates the Kauvery Hospital facilities in Trichy, ended Q4 FY26 with a sharp step-up in profitability. Total income for the quarter rose to 84.2 crore from 61.7 crore in Q4 FY25, a year-on-year growth of 36.3 percent. EBITDA increased to 27.8 crore with a margin of 33.0 percent, compared with 16.2 crore and a 26.3 percent margin a year ago. Profit after tax grew to 14.6 crore, taking PAT margin to 17.4 percent versus 7.3 percent in Q4 FY25.

For the full year FY26, total income increased to 310.8 crore from 234.7 crore in FY25, a growth of 32.5 percent. EBITDA rose to 93.0 crore, up 55.1 percent, and EBITDA margin expanded to 29.9 percent from 25.6 percent. PAT more than doubled to 46.7 crore from 21.4 crore. The year’s numbers indicate that operating leverage, better occupancies, and pricing lifted profitability as the company scaled its two-facility footprint.

Operating performance: occupancy held above 80 percent in Q4

The quarter was defined by strong utilisation. Average occupied beds per day were 267 in Q4 FY26 compared with 215 in Q4 FY25. Occupancy improved to 81 percent from 65 percent, even as census beds remained at 330 across the reported periods in the operating dashboard.

Pricing and case mix also improved. Blended ARPOB increased to 32,838 in Q4 FY26 from 30,586 in Q4 FY25. Average length of stay moved up to 5.0 days from 4.7 days. Out-patient volumes rose to 55,630 from 42,034, while in-patient discharges were 4,823 compared with 4,137 in Q4 FY25. ARPP for in-patients increased to 1,33,895 and ARPP for out-patients increased to 2,716 in the quarter.

Payor mix remained cash-heavy. In Q4 FY26, cash patients accounted for 70 percent of revenue, TPA and corporates were 23 percent, and government schemes were 7 percent. The mix is broadly stable versus the prior quarter and shows a modest shift toward cash versus the prior year.

Specialty mix: mother and child care and neurosciences lead

The company reported a diversified specialty mix, with meaningful contribution from high-acuity programs. For FY26, mother and child care services contributed 27 percent of revenue mix, while neuro science contributed 19 percent and gastro science contributed 12 percent. Plastic surgery, general medicine, and orthopaedics each contributed mid-single digits. The mix was similar in Q4 FY26, with mother and child care at 27 percent and neuro science at 18 percent.

This mix aligns with the hospital’s stated focus areas. The presentation highlights centres of excellence across mother and child care, neuro science, gastro science, orthopaedics, plastic surgery, critical care, and transplant programs including liver transplant and bone marrow transplant.

FY26 financial position: lower leverage and higher cash

FY26 ended with a stronger balance sheet profile. Total equity increased to 210.43 crore from 164.33 crore in FY25. Total borrowings were stated at 71.03 crore at the end of FY26, incurred for the new facility Maa Kauvery. Liquidity improved materially, with total cash balance including fixed deposits stated at 60.8 crore at the end of FY26 versus 17.5 crore in FY25.

The ratio disclosure reinforces this improvement. Net debt to EBITDA reduced to 0.11 times in FY26 from 1.07 times in FY25. Debt equity reduced to 0.34 from 0.50. Current ratio improved to 1.9 from 0.9 and interest coverage increased to 11.2 times from 6.4 times. The company also reported a DSCR of 5.1 times in FY26.

Cash flows show higher operating cash generation. Net cash from operating activities rose to 79.10 crore in FY26 from 57.58 crore in FY25. Investing cash outflow reduced to 16.93 crore in FY26 from 50.94 crore in FY25, while financing cash flow was negative 21.34 crore in FY26. Cash and cash equivalents rose to 50.02 crore at year-end compared with 9.19 crore at the end of FY25.

Capacity and strategy: two facilities and focus on execution

KMC Speciality Hospitals operates two healthcare facilities with 450 operational beds in Trichy, consisting of a 250-bed existing facility and the 200-bed Maa Kauvery facility. The company stated that Maa Kauvery, focused on mother and child care services, was operationalised on January 29, 2024.

The growth strategy described in the presentation is execution-led. It highlights a doctors engagement model aimed at attracting and retaining clinical talent, continued investment in technology, capacity expansion across legacy and new blocks, and quality and digital enablement. The company also notes academic enablement with over 44 DnB and diploma seats, indicating an intent to build a clinical pipeline.

The Q4 FY26 result suggests that utilisation and pricing are moving in the right direction, and that the two-facility structure is supporting scale. The key question for investors going forward is how sustainable the 80 percent plus occupancy levels are, and whether blended ARPOB can continue to improve without adverse payor mix shifts.

Takeaways

Q4 FY26 marked a strong quarter for Kauvery Hospital’s Trichy operations. Revenue growth was supported by higher occupancies and better realisations, and profitability expanded sharply with EBITDA margin at 33 percent. FY26 also showed balance sheet strengthening, with lower leverage metrics and significantly higher cash. With 450 operational beds and a specialty mix led by mother and child care and neurosciences, the company’s near-term execution will likely be judged on maintaining utilisation, protecting payor mix, and translating scale into consistent returns on capital.